Literature DB >> 23891230

Analogs of iso-azepinomycin as potential transition-state analog inhibitors of guanase: synthesis, biochemical screening, and structure-activity correlations of various selectively substituted imidazo[4,5-e][1,4]diazepines.

Saritha Tantravedi1, Saibal Chakraborty, Niti H Shah, James C Fishbein, Ramachandra S Hosmane.   

Abstract

Guanase is an important enzyme of the purine salvage pathway of nucleic acid metabolism and its inhibition has beneficial implications in viral, bacterial, and cancer therapy. The work described herein is based on a hypothesis that azepinomycin, a heterocyclic natural product and a purported transition state analog inhibitor of guanase, does not represent the true transition state of the enzyme-catalyzed reaction as closely as does iso-azepinomycin, wherein the 6-hydroxy group of azepinomycin has been translocated to the 5-position. Based on this hypothesis, and assuming that iso-azepinomycin would bind to guanase at the same active site as azepinomycin, several analogs of iso-azepinomycin were designed and successfully synthesized in order to gain a preliminary understanding of the hydrophobic and hydrophilic sites surrounding the guanase binding site of the ligand. Specifically, the analogs were designed to explore the hydrophobic pockets, if any, in the vicinity of N1, N3, and N4 nitrogen atoms as well as O(5) oxygen atom of iso-azepinomycin. Biochemical inhibition studies of these analogs were performed using a mammalian guanase. Our results indicate that (1) increasing the hydrophobicity near O(5) results in a negative effect, (2) translocating the hydrophobicity from N3 to N1 also results in decreased inhibition, (3) increasing the hydrophobicity near N3 or N4 produces significant enhancement of inhibition, (4) increasing the hydrophobicity at either N3 or N4 with a simultaneous increase in hydrophobicity at O(5) considerably diminishes any gain in inhibition made by solely enhancing hydrophobicity at N3 or N4, and (5) finally, increasing the hydrophilic character near N3 has also a deleterious effect on inhibition. The most potent compound in the series has a Ki value of 8.0±1.5μM against rabbit liver guanase.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biochemical inhibition studies; Imidazo[4,5-e][1,4]diazepines; Inhibitors of guanase; Organic synthesis and medicinal chemistry; Structure–activity relationship (SAR) studies; iso-Azepinomycin analogs

Mesh:

Substances:

Year:  2013        PMID: 23891230      PMCID: PMC3761942          DOI: 10.1016/j.bmc.2013.06.069

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  32 in total

1.  Inhibition of guanase in vitro by various pteridine compounds.

Authors:  L S DIETRICH; D M SHAPIRO
Journal:  J Biol Chem       Date:  1953-07       Impact factor: 5.157

2.  Crystallization and preliminary crystallographic analysis of Bacillus subtilis guanine deaminase.

Authors:  Yu Jui Chang; Chun Hsiang Huang; Chih Yung Hu; Shwu Huey Liaw
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-05-21

3.  A novel transition state analog inhibitor of guanase based on azepinomycin ring structure: Synthesis and biochemical assessment of enzyme inhibition.

Authors:  Saibal Chakraborty; Niti H Shah; James C Fishbein; Ramachandra S Hosmane
Journal:  Bioorg Med Chem Lett       Date:  2010-11-27       Impact factor: 2.823

4.  [Determination of CSF guanase activity in multiple sclerosis: a comparative study on various parameters to monitor the disease activity].

Authors:  Y Kaneshige; H Matsumoto; S Chiba; S Hashimoto; H Noro
Journal:  Rinsho Shinkeigaku       Date:  1989-07

5.  Rational design of novel antimicrobials: blocking purine salvage in a parasitic protozoan.

Authors:  J R Somoza; A G Skillman; N R Munagala; C M Oshiro; R M Knegtel; S Mpoke; R J Fletterick; I D Kuntz; C C Wang
Journal:  Biochemistry       Date:  1998-04-21       Impact factor: 3.162

6.  Cloning and characterization of human guanine deaminase. Purification and partial amino acid sequence of the mouse protein.

Authors:  G Yuan; J C Bin; D J McKay; F F Snyder
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

7.  A unique ring-expanded acyclic nucleoside analogue that inhibits both adenosine deaminase (ADA) and guanine deaminase (GDA; guanase): synthesis and enzyme inhibition studies of 4,6-diamino-8H-1-hydroxyethoxymethyl-8-iminoimidazo[4,5-e][1,3]diazepine.

Authors:  L Wang; R S Hosmane
Journal:  Bioorg Med Chem Lett       Date:  2001-11-19       Impact factor: 2.823

8.  Clinical significance of serum guanase activity in various liver diseases.

Authors:  G Shiota; J Fukada; T Ito; M Tsukizawa; M Yamada; M Sato
Journal:  Jpn J Med       Date:  1989 Jan-Feb

9.  Analogues of azepinomycin as inhibitors of guanase.

Authors:  V P Rajappan; R S Hosmane
Journal:  Nucleosides Nucleotides       Date:  1998-07

10.  Uridine kinase, adenylate kinase, and guanase in human lung tumors.

Authors:  O Greengard; J F Head; S L Goldberg
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.